Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LGND

Recent news which mentions LGND

< Previous 1 2 Next >
Roth Capital Maintains Buy Rating for Ligand Pharmaceuticals: Here's What You Need To Know
Tickers LGND
Tags BZI/AAR/UPDATE Benzinga Market News
From Benzinga
Tesla To $175? Here Are 10 Other Price Target Changes For Friday
Tickers AVO CLF CYTK KMX
Tags AVO Market News Analyst Ratings
From Benzinga
Some 'Transgenic Animal Platforms Are More Than Equal,' Analyst Initiating Coverage On OmniAb Says
Tickers LGND OABI
Tags Analyst Color OABI Initiation
From Benzinga
Ligand Pharma Issues Mixed Guidance For FY23
Tickers LGND
Tags Guidance Earnings News
From Benzinga
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
Tickers AAPL ACIW ALK AMGN
Tags MAT PGNY TNL
From MarketWatch
These small-cap stocks might make you the most money in 2023, based on two important data points
Tickers ADTN ALRM APPS BOOT
Tags SML GPRE VIOO
From MarketWatch
Earnings Outlook For Ligand Pharmaceuticals
Tickers LGND
Tags Benzinga Earnings Market News
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers ACOR ARCT CLSD CTSO
Tags PHAS BZI/TFM EDAP
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
Tickers APLS ARDX AZN FOLD
Tags YMAB Top Stories IMGN
From Benzinga
Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients
Tickers AHPA JNJ LGND
Tags European Medicines Agency Health Care AHPA
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
Tickers AIMD ANVS APLS BMRN
Tags LGND BMRN General
From Benzinga
Ligand Pharmaceuticals: Q2 Earnings Insights
Tickers LGND
Tags Benzinga LGND BZI/Recaps
From Benzinga
Barclays Maintains Overweight Rating for Ligand Pharmaceuticals: Here's What You Need To Know
Tickers LGND
Tags LGND Market News Analyst Ratings
From Benzinga
ASCO 2022: Surprising News in Cancer Research
Tickers ACLX ADPT BMY GILD
Tags Market News GILD JNJ
From Motley Fool
10 Biggest Price Target Changes For Monday
Tickers CODX CVNA CYTK FIGS
Tags TBLA Price Target Changes ZS
From Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Tickers AHPA APLS ASND ATHA
Tags News IMMP IBB
From Benzinga
Ligand To Spin-Off OmniAb Via Avista Capital-Backed SPAC Merger
Tickers AHPA LGND
Tags Health Care AHPA Biotech
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Tickers KBH KD KERN KIO
Tags NTP LPSN ONTF
From Benzinga
Recap: Ligand Pharmaceuticals Q4 Earnings
Tickers LGND
Tags Benzinga Market News Earnings
From Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
Tickers AGIO AMLX BMY CHRS
Tags General LGND Earnings
From Benzinga
Earnings Scheduled For February 17, 2022
Tickers AAWW AEE AEL AL
Tags News RGEN DGICA
From Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Tickers ADPT AEMD AGIO ALKS
Tags IBB ALKS INSM
From Benzinga
Ligand To Spin-Off OmniAb Platform Into Its Own Independent Company
Tickers LGND
Tags General Earnings Movers
From Benzinga
Ligand Pharmaceuticals Incorporated (LGND) Q3 2021 Earnings Call Transcript
Tickers LGND
Tags Market News LGND Recent Press Releases
From Motley Fool
Recap: Ligand Pharmaceuticals Q3 Earnings
Tickers LGND
Tags LGND BZI/Recaps Earnings
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Tickers ACHV ACIU AEMD AGEN
Tags IBB JNJ NUVA
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Tickers ABUS ACAD ACIU ADAP
Tags ACIU VCEL EYPT
From Benzinga
A bargain you can’t ignore: Small-cap stocks are trading at their second-lowest discount in 20 years
Tickers ACLS CIVI CYTK DGII
Tags VIOO ICHR SPSM
From MarketWatch
5 Biotech Stocks With 105% to 386% Upside, According to Wall Street
Tickers CRSP ICPT LGND NVAX
Tags Market News VXRT NVAX
From Motley Fool
Ligand Outlicenses BEPro Tech To Develop Oral COVID-19 Antivirals
Tickers LGND
Tags General COVID/19 Coronavirus Briefs
From Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.